Navigation Links
EntreMed Initiates Plans for China Office
Date:3/5/2012

a clinical-stage pharmaceutical company committed to developing ENMD-2076, a selective angiogenic kinase inhibitor, for the treatment of cancer.  ENMD-2076 is currently completing a multi-center Phase 2 study in ovarian cancer and completed several Phase 1 studies in solid tumors, multiple myeloma, and leukemia.  Additional information about EntreMed is available on the Company's web site at www.entremed.com and in various filings with the Securities and Exchange Commission (the SEC).

About ENMD-2076

ENMD-2076 is an orally-active, Aurora A/angiogenic kinase inhibitor with a unique kinase selectivity profile and multiple mechanisms of action. ENMD-2076 has been shown to inhibit a distinct profile of angiogenic tyrosine kinase targets in addition to the Aurora A kinase. Aurora kinases are key regulators of mitosis (cell division), and are often over-expressed in human cancers. ENMD-2076 also targets the VEGFR, Flt-3 and FGFR3 kinases which have been shown to play important roles in the pathology of several cancers. ENMD-2076 has shown promising activity in Phase 1 clinical trials in solid tumor cancers, leukemia, and multiple myeloma.  ENMD-2076 is currently completing a Phase 2 trial for ovarian cancer.

Forward Looking Statements         

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to the outlook for expectations for future financial or business performance, strategies, expectations and goals. Forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time.  Forward-looking statements speak only as of the date they are made, and no duty to update forward-looking statements is assumed.

Actual results could differ materially from those currently anticipated due to a number of f
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
2. EntreMed Raises $20 Million to Support Clinical Development Program
3. EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198
4. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
5. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
6. EntreMed to Present at The New York Society of Security Analysts Industry Conference
7. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
8. EntreMed Commences Continuous Dosing Clinical Trial For MKC-1
9. EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program
10. EntreMed to Highlight ENMD-2076 Kinase Inhibitor at 2008 AACR Annual Meeting
11. EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... -- China Biologic Products, Inc. (NASDAQ: CBPO, "China ... plasma-based biopharmaceutical company in China ... Taibang Biological Products Co., Ltd. ("Guizhou Taibang") entered ... Xinjiang Deyuan Bioengineering Co., Ltd. ("Xinjiang Deyuan") to ... to source no less than 500 tonnes of ...
(Date:9/2/2015)... Quebec , Sept. 2, 2015  Valeant Pharmaceuticals ... today announced that its affiliate has entered into a ... USA , Inc. (NASDAQ: SURG ) ... the upfront cash payment, Synergetics stockholders will receive additional ... specified sales milestones are achieved following the closing.  The ...
(Date:9/2/2015)... Delcath Systems, Inc. (NASDAQ: DCTH ), ... oncology with an emphasis on the treatment of primary ... participate in the upcoming 17 th Annual Rodman ... at the St. Regis Hotel in New York City.  ... and Chief Executive Officer, will present a corporate overview ...
Breaking Medicine Technology:China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 2China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 3China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 4China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 5Valeant Pharmaceuticals To Acquire Synergetics USA 2Valeant Pharmaceuticals To Acquire Synergetics USA 3Valeant Pharmaceuticals To Acquire Synergetics USA 4Valeant Pharmaceuticals To Acquire Synergetics USA 5Delcath To Present At The 17th Annual Rodman & Renshaw Conference 2Delcath To Present At The 17th Annual Rodman & Renshaw Conference 3
... 20, 2011 Perrigo Company (Nasdaq: PRGO; TASE) today ... acquire substantially all of the assets of Paddock Laboratories, ... generic pharmaceutical products for approximately $540 million in cash. ... a result of the acquisition of Paddock,s assets. The ...
... Jan. 20, 2011 Reportlinker.com announces that a ... catalogue: Hospital Angiography Census ... is the most comprehensive European market report on ... Radiology, Mammography, R&F, Angiography, CT, MRI,) and radiology ...
Cached Medicine Technology:Perrigo to Acquire Assets of Paddock Labs for $540 Million 2Perrigo to Acquire Assets of Paddock Labs for $540 Million 3Perrigo to Acquire Assets of Paddock Labs for $540 Million 4Perrigo to Acquire Assets of Paddock Labs for $540 Million 5Reportlinker Adds Hospital Angiography Census 2Reportlinker Adds Hospital Angiography Census 3
(Date:9/2/2015)... ... September 02, 2015 , ... Every year at this time, ... it. However, few are prepared to face the academic workload confronting them. They just ... haven’t prepared them since schools don’t teach students how to study. , “Bankers bank. ...
(Date:9/2/2015)... ... 02, 2015 , ... World Patent Marketing, a vertically integrated ... invention that protects people from crime and other hostile situations. , "The Security ... and Creative Director of World Patent Marketing. "The industry is growing at a ...
(Date:9/2/2015)... ... ... Ovarian cancer continues to be the deadliest of all gynecologic cancers. According ... lifetime is approximately 1 in 75. This year it is estimated that approximately 22,000 ... , There is no test to detect ovarian cancer. A Pap test does not ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... the pioneer in marine cosmetics introduces PIONNIÈRE XMF Perfection Youth Rich Cream ... cream combines breakthrough biotechnological anti-aging power with a lipid-replenishing marine oil for intense ...
(Date:9/2/2015)... ... September 02, 2015 , ... Canopy ... been named to the Inc. 5000 List, an independent ranking of the ... for 34 years, and this achievement puts Canopy in rarefied company. Over the ...
Breaking Medicine News(10 mins):Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 2Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 4Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 5Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 6Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 7Health News:National Ovarian Cancer Coalition's DFW Chapter Features First Annual Teal Lights Display This Friday, September 4th, "National Wear Teal Day" 2Health News:National Ovarian Cancer Coalition's DFW Chapter Features First Annual Teal Lights Display This Friday, September 4th, "National Wear Teal Day" 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 2Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 4Health News:Canopy Partners Named to 2015 Inc. 5000 Fastest Growing Companies List 2
... that about 44% of women are victims of intimate ... mental health. // Screening for it is inadequate, and ... and the June issue of the American Journal of ... in addressing this issue. ,With colleagues from ...
... that both lesbians and heterosexual men react in a similar ... to a previous study it was found that there were ... and homosexual men. Pheromones are sex-specific chemicals that send messages ... in animals, but their existence in humans is questionable. Researchers ...
... Health Research at King's College London said that British soldiers ... the researcher and his team are examining whether there had ... Iraq. Therefore they are comparing the mental and physical health ... who had not. In the end they found out that ...
... Pharmacology states that 10% or more accidental and unwanted pregnancies ... //as they have the advantage of easy access. ,UK ... University of Bradford looked at 203 females aged from 13 ... and community pharmacies. ,They discovered that those ...
... athletes seem to have a negative impact on their children's ... Journal of Sports Medicine. ,The findings are informed ... in the US, which looked at the role parents play ... all spent an average of 17 years in the business. ...
... recent BBC survey it is found that there is a ... that about one in seven patients// take illegal drugs on ... use is very common among patients. It is said that ... every year. But Oliver Treacy, borough director for mental health ...
Cached Medicine News:Health News:Research into Intimate Partner Violence 2Health News:Morning-After Pill At The Local Pharmacy Could Prevent Unwanted Pregnancies 2Health News:Morning-After Pill At The Local Pharmacy Could Prevent Unwanted Pregnancies 3Health News:Parents of Junior Athletes do More Harm than Good 2
... Bird and Cronin, ... manufacturer of Patient Footwear, ... Patient Care Products. Our ... highest quality and available ...
... viscoelastic insert runs alongside the Achilles ... and targeted intermittent compression during movement. ... irritation of the Achilles tendon is ... wedge (raises heel about 6 mm). ...
... while maintaining the ankle in functional alignment. ... soft, cushioning AliPlast™ foam liner. The cushioning ... the heel in a protective hammock, reducing ... in bed from side-lying to supine. Only ...
... combines the therapeutic benefits of controlled compression ... to minimize pain. The cuff is anatomically ... maximum cryotherapy. The Ankle Cryo/Cuff is one-size ... a pediatric size.,All Cryo/Cuffs can be ordered ...
Medicine Products: